News & Events

Home | News | Zeno Pathology obtained IVD CE-mark

Zeno Pathology obtained IVD CE-mark

WSK Medical, a company developing Artificial Intelligence (AI) solutions for (early) cancer detection, has received the IVD CE mark for their AI digital pathology solution called Zeno Pathology.

Zeno Pathology considerably reduces observer variability and manual analysis time whilst increasing the speed, consistency, and accuracy to analyse H&E and IHC stained breast cancer whole slide images. Zeno Pathology has the flexibility of being integrated in the existing digital workflow and is co-developed with the Computational Pathology lab at the Netherlands Cancer Institute.

If you want more information about Zeno Pathology, please contact us.

Share –

Related articles

Zeno AI featured article on Open Access Government

The successful launch and implementation of Zeno AI, the first of its kind real-time AI solution for early laryngeal (throat) cancer detection for ENT-surgeons, was the subject of an article published by Open Access Government.

 

World Summit AI – Exhibiter – 12-13th of October in Amsterdam

What is World Summit AI?

The world’s leading and largest AI summit gathers the global AI ecosystem of Enterprise, Big Tech, Startups, Investors and Science, the brightest brains in AI as speakers every October in Amsterdam to tackle head-on the most burning AI issues and set the global AI agenda. You can find more information here.

Empaia

WSK Medical part of the EMPAIA consortium

WSK Medical has signed a partnership agreement with the EMPAIA consortium. With this partnership, WSK Medical aims to add knowledge to the consortium about the development and deployment of AI solutions for early cancer detection.

Demo //

Book a demo

Want to learn more about our solutions?

Our website only uses essential cookies. These cookies are used to make the website function properly. By continuing your visit on our website, you understand this. All our privacy related matters can be found in our privacy policy.